January 26, 2018 / 7:13 AM / in 7 months

BRIEF-AstraZeneca Reports Positive Phase III Results For PT010 In COPD

Jan 26 (Reuters) - AstraZeneca Plc:

* AZ REPORTS PHASE III RESULTS FOR PT010 IN COPD

* ‍PT010 DEMONSTRATES SIGNIFICANT IMPROVEMENT IN 8 OUT OF NINE LUNG FUNCTION PRIMARY ENDPOINTS COMPARED WITH DUAL COMBINATION THERAPIES​

* ‍THERE WERE NO UNEXPECTED SAFETY OR TOLERABILITY SIGNALS FOR PT010 IDENTIFIED IN TRIAL​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below